. 2022 Jul 5;146(3):304–317. doi: 10.1111/ane.13667

TABLE 6.

Motor measurement values of gait, standing rotation and swing of the arms, in healthy control subjects and in PD patients

Movement	Motor parameter	Group	Right							Left
Movement	Motor parameter	Group	N	Mean	SD	Min.	Max.	Effect size (d)	p (adjusted)	N	Mean	SD	Min.	Max.	Effect size (d)	p (adjusted)
Gait (GTAF)	GT_Strd	C	49	11.3	1.3	9.0	14.5	0.6	.0081^*	50	11.2	1.2	9.0	14.0	0.9 ^a	.0007^*
	GT_Strd	P	46	13.7	5.2	10.5	44.5	0.6	.0081^*	42	14.0	4.5	8.5	34.5	0.9 ^a	.0007^*
	GT_Time	C	49	12.0	1.7	8.2	15.5	0.6	.0086^*	50	11.7	1.6	8.1	14.9	0.9 ^a	.0005^*
	GT_Time	P	46	14.7	6.0	10.0	48.5	0.6	.0086^*	42	15.1	5.3	9.0	33.7	0.9 ^a	.0005^*
	GT_H	C	49	0.2	0.1	0.0	0.4	0.9 ^a	.0008^*	50	0.1	0.1	0.1	0.4	0.5	.0282^*
	GT_H	P	20	0.1	0.0	0.0	0.2	0.9 ^a	.0008^*	19	0.1	0.0	0.0	0.2	0.5	.0282^*
	GT_Ang	C	49	73.9	9.6	52.9	92.7	0.6	.0127^*	50	91.1	7.0	71.8	104.2	1.7 ^a	<.00001^*
	GT_Ang	P	46	67.4	12.7	17.5	93.0	0.6	.0127^*	42	72.9	14.1	30.4	95.5	1.7 ^a	<.00001^*
	GT_RS	C	49	69.9	1.3	67.7	72.8	0.2	.2683	50	69.6	1.4	66.7	73.1	0.5	.0489^*
	GT_RS	P	46	69.5	2.0	64.4	73.7	0.2	.2683	42	70.7	3.1	67.0	82.2	0.5	.0489^*
Rotation (ROTA)	RO_Strd	C	50	3.4	0.6	1.5	5.5	1.0 ^b	.00005^*	50	3.5	0.7	2.0	5.5	1.0 ^b	.0002^*
	RO_Strd	P	45	5.2	2.5	3.0	18.0	1.0 ^b	.00005^*	41	5.5	2.9	3.0	18.5	1.0 ^b	.0002^*
	RO_Time	C	50	2.5	0.7	1.6	4.0	1.2 ^b	.00001^*	50	2.6	0.6	1.2	4.0	1.0 ^b	.0002^*
	RO_Time	P	45	4.2	2.0	2.0	13.5	1.2 ^b	.00001^*	41	4.9	3.4	1.8	18.2	1.0 ^b	.0002^*
	RO_STT	C	50	1.2	0.5	0.1	2.3	0.9 ^b	.0002^*	50	1.1	0.4	0.2	2.3	0.9 ^b	.0017^*
	RO_STT	P	45	2.0	1.2	0.5	6.7	0.9 ^b	.0002^*	41	2.6	2.5	0.6	13.3	0.9 ^b	.0017^*
	RO_Freq	C	50	1.4	0.3	0.9	2.2	0.3	.1813	50	1.4	0.3	0.9	2.9	0.7	.0073^*
	RO_Freq	P	45	1.3	0.3	0.8	2.1	0.3	.1813	41	1.2	0.3	0.7	2.2	0.7	.0073^*
	RO_RS	C	50	43.7	9.4	7.3	58.8	0.1	.6220	50	42.4	9.1	19.2	58.1	0.5	.0296^*
	RO_RS	P	45	44.7	9.1	23.6	62.8	0.1	.6220	41	47.4	10.0	24.4	76.0	0.5	.0296^*
Arms swinging (GTAH)	GT_Taps	C	49	12.5	2.0	4.5	18.0	0.6	.0130^*	48	12.9	1.4	10.5	17.5	0.4	.1529
	GT_Taps	P	48	14.6	4.6	7.0	36.5	0.6	.0130^*	47	13.9	3.6	7.0	29.0	0.4	.1529
	GT_Exc	C	49	70.0	26.4	10.8	122.8	1.2 ^b	<.00001^*	48	68.2	26.1	28.2	135.0	0.8 ^b	.0003^*
	GT_Exc	P	48	40.3	21.3	6.6	109.1	1.2 ^b	<.00001^*	47	45.5	28.6	6.3	117.3	0.8 ^b	.0003^*
	GT_wf	C	49	62.9	27.8	4.1	123.6	1.0 ^b	<.00001^*	48	75.3	25.6	32.7	129.4	0.9 ^b	.00007^*
	GT_wf	P	48	37.3	20.9	6.2	104.9	1.0 ^b	<.00001^*	47	49.7	29.7	4.0	115.3	0.9 ^b	.00007^*
	GT_IAV	C	49	131.5	17.6	93.4	177.5	0.6	.0115^*	48	138.4	15.6	103.3	170.5	0.3	.1471
	GT_IAV	P	48	144.8	28.3	102.2	228.5	0.6	.0115^*	47	147.9	37.4	108.9	332.7	0.3	.1471

Note: Statistical significance between the two groups investigated (p adjusted) and discriminant capacity (effect size). C: control group; P: PD patients group; Effect size: Cohen d.

^{^a}

Cohen d > 0.8 unilaterally.

^{^b}

Cohen d > 0.8 bilaterally.

p < .05.

Abbreviations: PD, Parkinson's disease; SD, standard deviation.